Substantial doubt about the company's ability to continue as a going concern.
“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”View the 10-Q filed Aug 10, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
On November 9, 2026, National Health Investors, Inc. entered indemnification agreements with each director and certain officer, including every executive officer, covering eligible expenses and liabilities to the maximum extent permitted by Maryland law.
National Health Investors cut 2026 guidance to $4.68 to $4.70 per share for NAIREIT and normalized NFFO and $236.6 million to $237.7 million for funds available for distribution, after third-quarter shop underperformance; investments are expected to total approximately $590 million.
National Health Investors reported $396.2 million of investment activity in 2026, with a portfolio mix of 77.4% leases and 15.7% SHOP, alongside a 6.9% WACY.
National Health Investors reported diluted net income of $11.47 per share for the quarter ended September 30, 2026, driven partly by a $541.6 million portfolio-sale gain; NAREIT FFO per diluted share rose 2.8% to $1.12.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. NHI completed $396.2 million of investments at a 7.5% average yield, expanded SHOP NOI and its NOI contribution, entered the fourth quarter with approximately $1 billion of liquidity and a sizable investment pipeline, and maintained a strong financial position. However, SHOP results fell short of expectations, occupancy growth was slower than anticipated, normalized FFO and FAD declined year over year, general and administrative expenses increased 26.8%, and full-year FAD guidance was reduced by $5 million at the midpoint.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $75.64M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net income $55.36M
+$25.55M Depreciation and amortization
+$15.81M Interest expense
+$213K Franchise, excise and other taxes
+$732K Income tax expense
-$59K Loan and realty gains, net
-$21.97M Gains on dispositions of real estate properties
+$0K Write-offs of transaction costs
= Adjusted EBITDA $75.64M
|
|||
| Bickford average occupancy rate | 84.7% | Q2 2026 filing | — |
| NAREIT FFO attributable to common stockholders per share non-GAAP | $1.19 | Three Months Ended June 30, 2026 filing | — |
| Normalized FAD attributable to common stockholders non-GAAP | $61.62M | Three Months Ended June 30, 2026 filing | — |
| Normalized FFO attributable to common stockholders per share non-GAAP | $1.19 | Three Months Ended June 30, 2026 filing | — |
| Number of properties in Total SHOP segment | 42 | Q2 2026 filing | — |
| Real Estate Investments portfolio occupancy ratio (Total) | 85.1% | Q1 2026 filing | — |
| Senior Living average occupancy rate | 86.3% | Q2 2026 filing | — |
| SHOP segment average occupancy rate | 85.1% | Q2 2026 filing | — |
| Total SHOP segment average occupancy rate | 85.9% | Q2 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHI
this stock
National Health Investors Inc
|
$3.09B | -17.6% | +12.1% | 4.4 | 4.5% |
|
WELL
Welltower Inc.
|
$179.34B | +31.7% | +35.6% | 106.3 | 2.4% |
|
VTR
Ventas, Inc.
|
$47.02B | +14.9% | +18.5% | 167.8 | 2.8% |
|
OHI
Omega Healthcare Investors Inc
|
$14.32B | +6.1% | +13.2% | 18.9 | 4.8% |
|
DOC
Healthpeak Properties, Inc.
|
$13.78B | +24.3% | +4.5% | 37.0 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
On November 9, 2026, National Health Investors, Inc. entered indemnification agreements with each director and certain officer, including every executive officer, covering eligible expenses and liabilities to the maximum extent permitted by Maryland law.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHI | -11.6% | -5.0% | -17.4% | -6.1% | -17.6% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -14.2% | -3.9% | -17.9% | -5.9% | -28.2% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
